Searching for the cause of Kawasaki disease - Cytoplasmic inclusion bodies provide new insight

Nature Reviews Microbiology

Volumn 6, Issue 5, 2008, Pages 394-401

  Rowley, Anne H ^a   Baker, Susan C ^b   Orenstein, Jan M ^c   Shulman, Stanford T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A;

ANTIBODY PRODUCTION; ANTIGEN DETECTION; ARTICLE; BACTERIUM IDENTIFICATION; CD8+ T LYMPHOCYTE; CELL INCLUSION; CHILD; CORONARY ARTERY ANEURYSM; DEVELOPED COUNTRY; HEART DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; ANTIGENS; CHILD; CORONARY ANEURYSM; CYTOPLASM; HUMANS; IMMUNOGLOBULIN A; INCLUSION BODIES; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLASMA CELLS;

EID: 42349104347     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1853     Document Type: Article

References (102)

1. Suzuki, A. et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr. Cardiol. 7, 3-9 (1986).
2. Newburger, J. W. et al. The treatment of Kawasaki syndrome with intravenous gammaglobulin. N. Engl. J. Med. 315, 341-347 (1986).
3. Kato, H. et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94, 1379-1385 (1996).
4. Newburger, J. W. et al. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation 110, 2747-2771 (2004).
5. Landing, B. H. & Larson, E. J. Pathologic features of Kawasaki disease. Am. J. Cardiovasc. Pathol. 1, 218-229 (1987).
6. Nakano, H., Saito, A., Ueda, K. & Nojima K. Clinical characteristics of myocardial infarction following Kawasaki disease: Report of 11 cases. J. Pediatr. 108, 198-203(1986).
7. Akagi, T. et al. Catheter interventional treatment in Kawasaki disease: A report from the Japanese Pediatric Interventional Cardiology Investigation Group. J. Pediatr. 137, 181-186 (2000).
8. Kitamura, S. et al. Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. J. Thorac. Cardiovasc. Surg. 107, 663-674 (1994).
9. Suzuki, A., Kamiya, T., Ono, Y., Okuno, M. & Yagihara, T. Aortocoronary bypass surgery for coronary arterial lesions resulting from Kawasaki disease. J. Pediatr. 116, 567-573 (1990).
10. Checchia, P. A., Pahl, E., Shaddy, R. E. & Shulman, S. T. Cardiac transplantation for Kawasaki disease. Pediatrics 100, 695-699 (1997).
11. Anderson, M. S., Todd, J. K. & Glode. M. P. Delayed diagnosis of Kawasaki syndrome: An analysis of the problem. Pediatrics 115 e428 (2005).
12. Rowley, A. H., Gonzalez-Crussi, F., Gidding, S. S., Duffy, C. E. & Shulman, S. T. Incomplete Kawasaki disease with coronary artery involvement. J. Pediatr. 110, 409-413 (1987).
13. Newburger, J. W. et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N. Engl. J. Med. 324, 1633-1636 (1991).
14. Wallace, C. A., French, J. W., Kahn, S. J. & Sherry, D. D. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 105, e78 (2000).
15. Yanagawa, H., Nakamura, Y., Kawasaki, T. & Shigematsu, I. Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86. Lancet 2, 1138-1139 (1986).
16. Kawasaki, T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16, 178-222 (1967).
17. Rowley, A. H., Eckerley, C. A., Jack, H. M., Shulman, S. T. & Baker, S. C. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J. Immunol. 159, 5946-5955 (1997).
18. Rowley, A. H. et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J. Infect. Dis. 182, 1183-1191 (2000).
19. Rowley, A. H., Shulman, S. T., Spike, B. T., Mask, C. A. & Baker, S. C. Oligodonal IgA response in the vascular wall in acute Kawasaki disease. J. Immunol. 166, 1334-1343 (2001).
20. Rowley, A. H. et al. Cloning the arterial IgA antibody response during acute Kawasaki disease. J. Immunol. 175, 8386-8391 (2005).
21. Rowley, A. H. et al. Detection of antigen in bronchial epithelium and macrophages in Acute Kawasaki disease by use of synthetic antibody. J. Infect. Dis. 190, 856-865 (2004).
22. Rowley, A. H. et al. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J. Infect. Dis. 192, 1757-1766 (2005).
23. Yanagawa, H., Yashiro, M., Nakamura, Y., Kawasaki, T. & Kato, H. Epidemiologic pictures of Kawasaki disease in Japan: From the nationwide incidence survey in 1991 and 1992. Pediatrics 95, 475-479 (1995).
24. Yanagawa, H. et al. Changes in epidemic patterns of Kawasaki disease in Japan. Pediatr Infect. Dis. J. 18, 64-66 (1989).
25. Dean, A. G., Melish, M. E., Hicks, R. & Palumbo, N. E. An epidemic of Kawasaki syndrome in Hawaii. J. Pediatr 100, 552-557 (1982).
26. Yanagawa, H. et al. Incidence of Kawasaki disease in Japan: The nationwide surveys of 1999-2002. Pediatr. Int. 48, 356-361 (2006).
27. Holman, R. C., Curns, A. T., Belay, E. D., Steiner, C. A. & Schonberger, L. B. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 112, 495-501 (2003).
28. Fujita, Y. et al. Kawasaki disease in families. Pediatrics 84, 666-669 (1989).
29. Uehara, R., Yashiro, M., Nakamura, Y. & Yanagawa, H. Kawasaki disease in parents and children, Acta Paediatr. 92, 694-697 (2003).
30. Burns, J. C. et al. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun. 6, 438-444 (2005).
31. Burns, J. C. et al. Genetic variations in the receptor-ligand pair CCR5-CCL3L1 are important determinants of susceptibility to Kawasaki disease. J. Infect. Dis. 192, 344-349 (2005).
32. Onouchi, Y. et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nature Genet. 40, 35-42 (2007).
33. Onouchi, Y. et al. A genomewide linkage analysis of Kawasaki disease: Evidence for linkage to chromosome 12. J. Hum. Genet. 52, 179-190 (2007).
34. Bell, D. M. et al. Kawasaki syndrome: Description of two outbreaks in the United States. N. Engl. J. Med. 304, 1568-1575 (1981).
35. Kato, H. et al. Variant strain of Propionibacterium acnes: A clue to the aetiology of Kawasaki disease. Lancet 2, 1383-1387 (1983).
36. Hamashima, Y., Kishi, K. & Tasaka, K. Rickettsia-like bodies in infantile acute febrile mucocutaneous lymph node syndrome. Lancet 2, 42 (1973).
37. Patriarca, P. A. et al. Kawasaki syndrome: Association with the application of rug shampoo. Lancet 2, 578-580 (1982).
38. Lin, F. Y., Bailowitz, A., Koslowe, P., Israel, E. & Kaslow, R. A. Kawasaki syndrome: A case-control study during an outbreak in Maryland. Am. J. Dis. Child. 139, 277-279 (1985).
39. Klein, B. S. et al. Kawasaki syndrome: A controlled study of an outbreak in Wisconsin. Am. J. Epidemiol. 124, 306-316 (1986).
40. Shulman, S. T. & Rowley, A. H. Does Kawasaki disease have a retroviral etiology? Lancet 2, 545-546 (1986).
41. Burns, J. C. et al. Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature 323 814-816 (1986).
42. Melish, M. E. et al. Absence of significant RNA-dependent DNA polymerase activity in lymphocytes from patients with Kawasaki syndrome. Nature 337, 288-290 (1989).
43. Rowley, A. et al. Failure to confirm the presence of a retrovirus in cultured lymphocytes from patients with Kawasaki syndrome. Pediatr. Res. 29, 417-419 (1991).
44. Leung, D. Y. M. et al. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 342, 1385-1388 (1993).
45. Terai, M. et al. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J. Infect. Dis. 172, 558-561 (1995).
46. Leung, D. Y. M. et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J. Pediatr. 140, 742-746 (2002).
47. Esper, F. et al. Association between a novel human coronavirus and Kawasaki disease. J. Infect. Dis. 191, 499-502 (2005).
48. Shimizu, C. et al. Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease. J. Infect. Dis. 192, 1767-1771 (2005).
49. Dominguez, S. R., Anderson, M. S., Glode, M. P., Robinson, C. C. & Holmes, K. V. Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki disease. J. Infect. Dis. 194, 1697-1701 (2006).
50. Catalano-Pons, C. et al. Detection of human bocavirus in children with Kawasaki disease. Clin. Microbiol. Infect. 13, 1220-1222 (2007).
51. Whitby, D. et al. Isolation of measles virus from a child with Kawasaki disease. Lancet 338, 1215 (1991).
52. Embil, J. A., McFarlane, E. S., Murphy, D. M., Krause, V. W. & Stuart, H. B. Adenovirus type 2 isolated from a patient with fatal Kawasaki disease. Can. Med. Assoc. J. 132, 1400 (1985).
53. Maury, C. P. J., Salo, E. & Pelkonen, P. Elevated circulating tumor necrosis factor alpha in patients with Kawasaki disease. J. Lab. Clin. Med. 113, 651-654 (1989).
54. Hirao, J., Hibi, S., Andoh, T. & Ichimura, T. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int. Arch. Allergy Immunol. 112, 152-156 (1997).
55. Lin, C. Y., Lin, C. C., Hwang, B. & Chiang, B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J. Pediatr. 121, 924-926 (1992).
56. Ueno, Y. et al. The acute phase nature of interleukin 6: Studies in Kawasaki disease and other febrile illnesses. Clin. Exp. Immunol. 76, 337-342 (1989).
57. Nomura, Y., Masuda, K., Maeno, N., Yoshinaga, M. & Kawano, Y. Serum levels of interleukin-18 are elevated in the subacute phase of Kawasaki syndrome. Int. Arch. Allergy Immunol. 135, 161-165 (2004).
58. Abe, J. et al. Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc. Natl Acad. Sci. USA 89, 4066-4070 (1992).
59. Abe, J. et al. Characterization of T cell repertoire changes in acute Kawasaki disease. J. Exp. Med. 177, 791-796 (1993).
60. Curtis, N., Zheng, R., Lamb, J. R. & Levin, M. Evidence for a superantigen mediated process in Kawasaki disease. Arch. Dis Child. 72, 308-311 (19951).
61. Yoshioka, T. et al. Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology 96, 465-472 (1999).
62. Brogan, P. A., Shah, V., Clarke, L. A., Dillon, M. J. & Klein, N. T cell activation profiles in Kawasaki syndrome. Clin. Exp. Immunol. 151, 267-274 (2008).
63. Pietra, B. A., Belnocencio, J., Giannini, E. H. & Hirsch, R. TCR V beta family repertoire and T-cell activation markers in Kawasaki disease. J. Immunol. 153, 1881-1888 (1994).
64. -helper cells. Clin. Exp. Immunol. 99, 276-282 (1995).
65. Mancia, L. et al. Characterization of the T-cell receptor V-β repertoire in Kawasaki disease. Scand. J. Immunol. 48, 443-449 (1998).
66. Sourdive, D. J. D. et al. Conserved T cell receptor repertoire in primary memory CD8 T cell responses to an acute rat infection. J. Exp. Med. 188, 71-82 (1998).
67. Deckhut, A. M. et al. Prominent usage of V beta 8.3 T cells in the H-2D-restricted response to an influenza A virus nucleooprotein epitope. J. Immunol. 151, 2658-2666 (1993).
68. Chen, D., Lee, F., Cebra, J. J. & Rubin, D. H. Predominant T-cell receptor Vβ usage of intraepithelial lymphocytes during the immune response to enteric reovirus infection. J. Virol. 71, 3431-3436 (1997).
69. Case, S. C., Kelly, J. M. & Carbone, F. R. Characterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential V beta bias. J. Virol. 69, 5849-5852 (1995).
70. Kashii, Y. et al. Analysis of T-cell receptor V beta repertoire in liver-infiltrating lymphocytes in chronic hepatitis C. J. Hepatol. 26, 1462-470 (1997).
71. + T cells in Kawasaki disease. J. Immunol. 159, 481-486 (1997).
72. Matsuhara, K. et al. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease. Clin. Exp. Immunol. 143, 427-434 (2006).
73. Nomura, Y., Yoshinaga, M., Masuda, K., Takei, S. & Miyata, K. Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome. J. Infect. Dis. 185, 1677-1680 (2002).
74. Gupta-Malhotra, M., Viteri-Jackson, A., Thomas, W. & Zabriskie, J. B. Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease. Exp. Mol. Pathol. 76, 117-121 (2004).
75. Terai, M. et al. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J. Infect. Dis. 172, 558-561 (1995).
76. Grunebaum, E. et al. The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies. Clin. Exp. Immunol. 130, 233-240 (2002).
77. Amano, S. et al. General pathology of Kawasaki disease. Acta Pathol. Jpn. 30, 681-694 (1980).
78. Yutani, C. et al. Histopathological study on right endomyocardial biopsy of Kawasaki disease. Br. Heart J. 43, 589-592 (1980).
79. Vasukawa, K. et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 105, 766-769 (2002).
80. Brown, T. J. et al. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki diseare. J. Infect. Dis. 184, 940-943 (2001).
81. Gavin, P. J., Crawford, S. E., Shulman, S. T., Garcia, F. L. & Rowley, A. H. Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler. Thromb. Vasc. Biol. 23 576-581 (2003).
82. Miura, M., Garcia, F. L., Crawford, S. E. & Rowley, A. H. Cell adhesion molecule expression in coronary artery aneurysms in acute Kawasaki disease. Pediatr. Infect. Dis. J. 23, 931-936 (2004).
83. Suzuki, A. et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease, Circulation 101 2935-2941 (2000).
84. Freeman, A. F. et al. Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium. Pediatr. Cardiol. 26, 578-584 (2005).
85. Shingadia, D., O'Gorman, M., Rowley, A. H. & Shulman, S. T. Surface and cytoplasmic immunoglobulin expression on circulating B-lymphocytes in acute Kawasaki disease. Pediatr. Res. 50, 538-543 (2001).
86. Murphy, F. A., Gibbs, E. P. J., Horzinek, M. C. & Studdert, M. J. (eds) Veterinary Virology: The Third Edition 277-292; 391-404; 411-428; 447-454 (Academic, San Diego, 1999).
87. Rowley, A. H. et al. RNA-containing cytoplasmic inclusion, bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS ONE 3, e1582 (2008).
88. Maiztegui, J. I., Fernandez, N. J. & deDamilano, A. J. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 2, 1216-1217 (1979).
89. Enria, D. A., Briggiler, A. M., Fernancez, N. J., Levis, S. C. & Maiztegui, J. I. Importance of dose of neutralizing antibodies in treatment of Argentine haemorrhagic fever with immune plasma. Lancet 2, 255-256 (1984).
90. Kenyon, R. H., Condie, R. M., Jahrling, P. B. & Peters, C. J. Protection of guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: Importance of elimination of infected cells. Microb. Pathog. 9, 219-226 (1990).
91. Amano, S., Hazama, F. & Hamashima, Y. Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes. Jpn. Circ. J. 43, 633-643 (1979).
92. Naoe, S. et al. Pathological observations concerning the cardiovascular lesions in Kawasaki disease. Cardiol. Young 1 212-220 (1991).
93. Amano, S., Hazama, F. & Hamashima, Y. Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions. Jpn. Circ. J. 43, 741-748 (1979).
94. Freeman, A. F. et al. Inflammatory pulmonary nodules in Kawasaki disease. Pediatr. Pulmonol. 36, 102-106 (2003).
95. Terai, M. et al. Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute Kawasaki disease. Pediatr. Infect. Dis. J. 21, 777-780 (2002).
96. + T cells in coronary artery lesions in patients with Kawasaki disease. Exp. Mol. Pathol. 83, 93-103 (2007).
97. Terai, M. et al. Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease. Am. J. Cordiol. 60, 555-559 (1987).
98. Orlowski, J. P. & Mercer, R. D. Urine mercury levels in Kawasaki disease. Pediatrics 66, 633-636 (1980).
99. Ohtaki, C., Tomiyama, T., Suzuki, M., Hayakawa, H. & Kaga, M. Leptospiral antibody and MLNS. J. Pediatr. 93, 896 (1978).
100. Shinomiya, N. et al. Variant Streptococcus sanguis as an etiologic agent of Kawasaki disease. Prog. Clin. Biol. Res. 250 571-572 (1987).
101. Catalano-Pons, C. et al. Primary cytomegalovirus infection, atypical Kawasaki disease, and coronary aneurysms in 2 infants. Clin. Infect. Dis. 41, e53-e56 (2005).
102. Lee, S. J., Lee, K. Y., Han, J. W., Lee. J. S. & Whang, K. T. Epstein Barr virus antibodies in Kawasaki disease. Yonsei Med. J. 47 475-479 (2006).